Evidence map›Paper›PMID 26663912›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.

Coral K Wille, Dhananjay M Nawandar, Amanda N Henning, Shidong Ma, Kayla M Oetting, Dennis Lee, Paul Lambert, Eric C Johannsen, Shannon C Kenney

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Arginine Metabolism SupportsbioRxiv : the preprint server for biology · 2025
    Article
  6. Chromatin Control of EBV Infection and Latency.Current topics in microbiology and immunology · 2025
    Article
  7. Article
  8. Review
  9. Epigenetic control of the Epstein-Barr lifecycle.Current opinion in virology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Coral K WilleDepartment of Medical Microbiology and Immunology, Wisconsin Institutes for Medical Research (WIMR) II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Dhananjay M NawandarCellular and Molecular Biology Graduate Program, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Amanda N HenningDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Shidong MaDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Kayla M OettingDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Dennis LeeDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Paul LambertDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705;
Eric C JohannsenDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705; Department of Medicine, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705.
Shannon C KenneyDepartment of Oncology, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705; Department of Medicine, WIMR II, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705 skenney@wisc.edu.
University of Wisconsin–Madison · USWisconsin Institutes for Discovery · US

Funding

Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WILLIAM M. SUGDEN · 1985 to 2026
$53.1M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseasesR01DE023939 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI JOHANNSEN, ERIC C, KENNEY, SHANNON CELESTE · 2013 to 2017
$2.9M
Molecular and Theraputic Studies on HPV-associated Anal CancerR01CA171873 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2013 to 2016
$1.2M
NCI NIH HHS 5-P01-CA022443-38NCI NIH HHS P01 CA022443NCI NIH HHS R01 CA171873NIAID NIH HHS T32 AI078985NIDCR NIH HHS 5-R01-DE023939-02NIDCR NIH HHS R01 DE023939
6 · The paper itself

Abstract

Latent Epstein-Barr virus (EBV) infection and cellular hypermethylation are hallmarks of undifferentiated nasopharyngeal carcinoma (NPC). However, EBV infection of normal oral epithelial cells is confined to differentiated cells and is lytic. Here we demonstrate that the EBV genome can become 5-hydroxymethylated and that this DNA modification affects EBV lytic reactivation. We show that global 5-hydroxymethylcytosine (5hmC)-modified DNA accumulates during normal epithelial-cell differentiation, whereas EBV+ NPCs have little if any 5hmC-modified DNA. Furthermore, we find that increasing cellular ten-eleven translocation (TET) activity [which converts methylated cytosine (5mC) to 5hmC] decreases methylation, and increases 5hmC modification, of lytic EBV promoters in EBV-infected cell lines containing highly methylated viral genomes. Conversely, inhibition of endogenous TET activity increases lytic EBV promoter methylation in an EBV-infected telomerase-immortalized normal oral keratinocyte (NOKs) cell line where lytic viral promoters are largely unmethylated. We demonstrate that these cytosine modifications differentially affect the ability of the two EBV immediate-early proteins, BZLF1 (Z) and BRLF1 (R), to induce the lytic form of viral infection. Although methylation of lytic EBV promoters increases Z-mediated and inhibits R-mediated lytic reactivation, 5hmC modification of lytic EBV promoters has the opposite effect. We also identify a specific CpG-containing Z-binding site on the BRLF1 promoter that must be methylated for Z-mediated viral reactivation and show that TET-mediated 5hmC modification of this site in NOKs prevents Z-mediated viral reactivation. Decreased 5-hydroxymethylation of cellular and viral genes may contribute to NPC formation.

Indexed as

DNA MethylationBase SequenceBinding SitesCarcinomaCell DifferentiationCell LineCell Line, TumorDioxygenasesDNA-Binding ProteinsGenome, ViralHEK293 CellsHerpesvirus 4, HumanHost-Pathogen InteractionsHumansImmediate-Early ProteinsImmunoblottingBRLF1 protein, Human herpesvirus 4BZLF1 protein, Herpesvirus 4, HumanDioxygenasesDNA-Binding ProteinsImmediate-Early ProteinsProto-Oncogene ProteinsTET2 protein, humanTrans-Activators5hmCEBVlytic reactivationNPC

Identifiers

PMID26663912
PMCPMC4703011
OpenAlexW2190159329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.